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INTRODUCTION
Increases in apoptotic chondrocytes have been reported in
rheumatoid arthritis (RA) and osteoarthritis (OA) cartilages
in situ (1, 2), and since any conditions that compromise chon-
drocyte survival will have detrimental effects on the mainte-
nance of proper articular cartilage, the mechanism of chon-
drocyte apoptosis has been the focus of interest recently as one
of the pathogenetic factors leading to joint cartilage degrada-
tion. The signaling cascade that triggers apoptosis in chondro-
cytes has been extensively studied. Cultured chondrocytes
undergo apoptosis in response to various stimuli, including
serum deprivation (3), FAS-ligand or anti-FAS/CD95-antibod-
ies (4), and nitric oxide (NO) donor sodium nitroprusside (5).
Among the cytokines that mediate cartilage degradation,
tumor necrosis factor alpha (TNF- ) is unique in that it is
related with the signaling mechanism of both matrix degra-
dation and cell death. Signaling cascade of TNF- cytotoxi-
city begins with the binding of TNF- to the p55 TNF recep-
tor (TNFR), receptor trimerization, the recruitment of TNFR-
associated death protein and TNFR associated factor 2, Fas-
associated protein with death domain (FADD), and caspase-8
(6). Both TNF-R55 and TNF-R75 are expressed constitu-
tively on human articular chondrocytes (7). Human articular
chondrocytes are resistant to TNF-alpha induced cell death
and undergo cell death only when they are treated with TNF-
alpha in the presence of transcription inhibitor or proteasome
inhibitor (8). TNF-alpha receptor signaling activates numer-
ous downstream signaling cascades which include caspase 8,
NF- B, and mitogen activated protein (MAP) kinases. Al-
though the proapoptotic role of caspase 8 and anti- apoptotic
role of NF- B have been well delineated, the role of MAP
kinase in TNF-alpha signaling in light of apoptosis induction
is not settled. There are 3 distinct subtypes of MAP kinases
identified in mammalian cells: extracellular signal-regulated
kinases (ERK), c-Jun N-terminal protein kinase (JNK), and
p38 kinases. A recent report showed that the inhibition of
ERK-1/2 enhances sodium nitroprusside (SNP)-induced
apoptosis, whereas the inhibition of p38 kinase blocks it in
rabbit articular chondrocytes (9). The role of JNK activation
in TNF-alpha mediated chondrocyte death signaling is not
known.
The objective of this study was to delineate the pattern of
JNK activation in TNF-alpha mediated chondrocyte death.
We observed the influence of inhibition of JNK dephospho-
rylation, which leads to sustained activation of JNK, on TNF-
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Prologation of c-Jun N-Terminal Kinase is Associated with Cell Death
Induced by Tumor Necrosis Factor Alpha in Human Chondrocytes
The aim of this study was to elucidate the role of JNK signaling pathway involved
in tumor necrosis factor-alpha (TNF- )-induced death of chondrocytes. Primary chon-
drocyte cultures were obtained from human knee osteoarthritis cartilages. First pas-
sage chondrocytes were treated with TNF- and various potentiators, and cell death
was measured with MTT assay. C-Jun N terminal kinase (JNK) activation was inves-
tigated with the solid phase kinase assay. Expression of apoptosis-related molecule
was assayed with Western blot. Chondrocytes were resistant to TNF- -induced cell
death. In contrast, pretreatment with actinomycin D, the phosphatase inhibitor vana-
date or MAP kinase phosphatase-1 (MKP-1) inhibitor Ro318220 invariably led to
chondrocyte death. While TNF-alpha alone stimulated a single, brief JNK activity,
a second JNK peak was observed when the cells were pretreated with actinomycin
D. When the cells were pretreated with vanadate or Ro318220, TNF-alpha-induced
JNK activation was greatly prolonged, which was associated with the induction of
cell death. The expression of Bcl-2 and Mcl-1 decreased significantly in conditions
of cell death. In conclusions, our data suggest that chondrocyte death induced by
TNF-alpha is associated with sustained JNK activation. This effect may be due to
downregulation of TNF-alpha induced phosphatase that inactivates JNK and of Bcl-2
family proteins. 
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alpha mediated chondrocyte death, as well as on the expres-
sion of apoptosis related proteins.
MATERIALS AND METHODS
Reagents
Recombinant human TNF- was purchased from R & D
(Minneapolis, MN, U.S.A.). Pan-caspase inhibitor (z-VAD-
FMK) was purchased from Biomol (Plymouth Meeting, PA,
U.S.A.). Anti-JNK, anti-I B, and anti-phosphoI B were
purchased from New England Biolab (Beverly, MA, U.S.A.),
anti-Bcl-2 from Transduction Laboratory (Lexington KY,
U.S.A.), anti-Bax, anti-FLIP (Flice inhibitory protein) and
anti-caspase-3 from Pharmingen (San Diego, CA, U.S.A.),
and anti-p53, anti-p21, anti-MDM2, anti-p65 from Santa
Cruz (Santa Cruz, CA, U.S.A.). All other reagents were ob-
tained from Sigma (St. Louis, MO, U.S.A.) unless specified
otherwise.
Chondrocyte culture
Cartilage samples were obtained from the tibial plateau of
knee OA patients. Pieces of articular cartilage were cut, minc-
ed, and incubated with trypsin/collagenase (Sigma, St. Louis,
MO) in DMEM until the fragments were digested. Released
cells were seeded at 2×106/plate in 10 cm culture plates in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented
with 10% fetal calf serum, 1% L-glutamine, 1% Fungizone
(Gibco, Grand Island, NY, U.S.A.) and penicillin/streptomycin
(150 units/mL and 50 mg/mL each). After about 7-10 days,
confluent chondrocytes were split once, seeded at high den-
sity, and these first passage chondrocytes were used in the sub-
sequent experiments. 
Induction of apoptosis
Before adding TNF- , the medium containing 10% FCS
was replaced with medium containing 0.5% FCS, and the
chondrocytes were incubated overnight. TNF- was added
to the medium in a concentration of 10 ng/mL. The poten-
tiation of apoptosis was attempted with the following com-
pounds: actinomycin D, sodium vanadate, or Ro318220 by
adding each compound to the media 1 hr prior to TNF- .
SAPK/JNK assay
SAPK/JNK activity was measured using a solid phase kinase
assay method. Briefly, 100 microgram of cell lysate was incu-
bated with 2 microgram of GST-c-Jun beads (Cell signaling
technology, Beverly, MA, U.S.A.) at 4℃overnight with gen-
tle rocking. The beads were then pelleted, washed and resus-
pended in kinase buffer (25 mM Tris pH 7.5, 5 mM  -glyc-
erolphosphate, 2 mM DTT, 0.1 mM Na3VO4, 10 mM MgCl2)
containing final concentrations of 100  M ATP. After incu-
bation at room temperature for 30 min, the reaction was ter-
minated by adding SDS sample buffer. The proteins were sep-
arated on 12% SDS-PAGE, and blotted with phospho-c-Jun
antibody (Cell signaling technology, Beverly, MA).
Quantification and verification of cell death
The amount of cell death was quantitated by using the 3-
(4, 5-dimethylthiazol-2-yl)-2, 5 diphenyltetrazdium bromide
(MTT) assay, as described (10). Briefly, chondrocytes were
seeded at 5×104/100  L/well in 96 well microtiter plates,
and incubated with TNF- with or without various potentia-
tors. MTT was added to each well to a final concentration of
0.125 mg/mL, and the plate incubated at 37℃ for 3 hr, after
which, the formazan product was solubilized with 100  L of
dimethylsulfoxide (DMSO) and the optical density was read
at a wavelength of 595 nm. The percentage of cell survival
was calculated by taking the optical density of cells given a
particular treatment, dividing this by the optical density of
untreated, control cells, and then multiplying by 100. Apop-
tosis was also verified by flow cytometry. For analysis of sub-
diploid cells, chondrocytes were trypsinized after treatment
and sedimented. Obtained cell pellets were fixed in 70%
ethanol, and stained in 100  g/mL propidium iodide solu-
tion containing 50  g/mL RNase for 15 min. For annexin
V-FITC/propidium iodide (PI) labeling, cells were collected
and resuspended in cold binding buffer (10 mM HEPES/
NaOH, pH 7.4, 140 mM NaCl, 2.5 mM CaCl2) to a final
concentration of 1×106/mL. Aliquots of 1×105 cells were
incubated with 5  L of annexin-V-FITC and 5  g/mL of PI.
After 15 min at room temperature, 400  L of binding buffer
was added before flow cytometric analysis. For each sample,
104 cells were analyzed on a FACS II flow cytometer (Becton
Dickinson, Mountain View, CA, U.S.A.). 
Electrophoretic mobility shift assay (EMSA)
Nuclear extracts from chondrocytes were prepared from 2
×106 cells as described previously with minor modifications
(11). Protein content was measured and 5  g portions of ex-
tracts were used for the binding reaction. A consensus double-
stranded NF- B probe was obtained from Promega (Madison,
WI, U.S.A.), and end-labeled by using  -32P-adenosine-5-
triphosphate. Nuclear extracts were incubated in gel binding
buffer (Promega, Madison, WI, U.S.A.) in a volume of 9  L.
Afterwards, the end-labeled probe was added (100,000 cpm/
sample). Samples were then incubated for 20 min and loaded
onto 4% nondenaturing polyacrylamide gel. Electrophoresis
was run for 3 hr in a cold room. Protein complexes were iden-
tified by autoradiography. JNK Activation in TNF-alpha Mediated Chondrocyte Death 569
Western blot
Cellular protein was extracted in lysis buffer containing 50
mM sodium acetate, pH 5.8, 10% v/v SDS, 1 mM EDTA,
1 mM phenylmethylsulfonyl fluoride, and 1  g/mL aprotinin
at 4℃. Samples were electrophoresed on 12% SDS-PAGE
gel, transfered, and Ponceau S staining of PVDF membrane
was routinely performed to roughly confirm equal loading
of protein before every Western blot procedure. Blots were
blocked with Tris buffered saline (TBS) containing 5% non-
fat milk at room temperature for 1 hr, and incubated with
respective antibodies overnight at 4℃. The blots were then
incubated with 1:5,000 peroxidase-conjugated goat anti-
mouse or anti-rabbit IgG (Biorad, Hercules, CA, U.S.A.) for
1 hr. Bound immunoglobulin was detected by using an en-
hanced chemiluminescence kit (Amersham, Bucks, U.K.).
Data Analysis
Data are expressed as mean±SD. Statistical analysis was
carried out between control and each treatment condition
by using the paired t-test, and significance was established
at the 95% confidence level (p<0.05).
RESULTS
The pattern of activation of the JNK in response to TNF-
alpha
Vanadate and Ro318220 are protein phosphatase inhibitors,
which is known to inhibit the tyrosine phosphatases (12).
Treatment with vanadate and Ro318220 inactivate protein
phosphatases that dephosphorylate JNK, thereby prolonging
the activation of JNK by TNF-alpha (13). First, we tried to
define the pattern of activation of the JNK in response to
TNF-alpha in Ro318220 or vanadate pretreated chondro-
cytes. Treatment with 10 ng/mL of TNF-alpha led to prompt
phosphorylation of JNK, first apparent after 5 min, and last-
ing about 15 min (Fig. 1). Activation of JNK, as detected
by a solid phase kinase assay of phosphorylated c-Jun, was
significantly prolonged in Ro318220 or vanadate pretreated
chondrocytes, as was expected, exhibiting about 5 hr of phos-
phorylation. Actinomycin D, another potentiator of TNF-
alpha mediated chondrocyte death (8) also led to prolonged
activation of JNK. In this case, the first JNK phosphoryla-
tion band disappeared and then reappeared after 240 min of
TNF-alpha treatment, lasting until 5 hr.
The influence of phosphatase inhibitors on TNF-alpha
induced chondrocyte death
In order to define the influence of phosphatase inhibitors
on chondrocyte death, we analyzed cell death in each treat-
ed chondrocytes. As was reported previously in human OA
chonrocytes (8), the treatment of chondrocytes with TNF-
alpha alone failed to reveal any significant degree of cell death.
However, pretreatment with 500  M of vanadate or 10  M
Ro318220 led to significant amount of cell death in chondro-
cytes treated with 10 ng/mL of TNF-alpha. To assess the extent
of cell death according to incubation time, cell viability was
determined by MTT assay after 12, 24, 36, and 48 hr of incu-
bation (Fig. 2A). Pre-treatment with vanadate or Ro318220
significantly affected cell viability in a time dependent man-
ner and cell death significantly increased 12 hr after treatment
(p<0.0001). The extent of cell death was more profound in
Ro318220 pretreated chondrocytes compared to vanadate
pretreated chondrocytes. Treatment with Ro318220 or vana-
date alone also decreased chondrocyte viability, but the extent
of cell death was not as marked as in co-treatment with TNF-
alpha. Apoptosis was also verified by flow cytometry analysis
of subdiploid fraction (Fig. 2B) and annexin V/propidium
iodide stating (Fig. 2C), but the percentage of apoptotic chon-
drocytes as revealed by this method tended to be lower com-
pared to that analyzed with MTT assay. Caspase 3 processing
was observed by immunoblot as early as 6 hr after Ro318220/
TNF- or vanadate/TNF- treatment, which occurred before
apoptotic cell death was discernible (Fig. 2D). In order to
verify the involvement of the caspase cascade in Ro318220
or vanadate facilitated TNF- mediated chondrocyte death,
we performed an inhibition assay using a pan-caspase inhibi-
tor, zVAD-FMK. As is shown in Fig. 2E, cell death by both
Ro318220/TNF- or vanadate/TNF-alpha was effectively
inhibited by zVAD-FMK.
The influence of phosphatase inhibitors on TNF-alpha
induced NF- B activation
Next, we examined the influence of Ro318220 and vana-
Fig. 1. Patterns of c-Jun N terminal kinase (JNK) phosphorylation
in human chondrocytes after treatment with TNF-alpha with or with-
out vanadate, Ro318220, or actinomycin D. Both vanadate and
Ro318220 increase the intensity and duration of JNK phosphory-
lation. Actinomycin D induces prolongation of SAPK/JNK activa-
tion, yielding second activation peak at 240 min of treatment. JNK
activation was assessed by solid phase kinase assay. Data are
representative of samples from 3 donors. 
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date on TNF-alpha induced NF- B activation and I B degra-
dation in chondrocytes, which is related with survival signal-
ing pathway in response to TNF-alpha. Chondrocytes respond-
ed by translocation of NF- B and degradation of I B after
treatment with TNF-alpha, and pretreatment with Ro318220
or vanadate did not exhibit any significant influence on this
response (Fig. 3) Phosphorylation of I B was not affected,
either.
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Fig. 2. (A) Kinetics of chondrocyte death induced by 10 ng/mL of TNF- after 1 hr pretreatment with 500  M vanadate or 10  M Ro318220.
Cell death increases significantly after 12 hr of treatment detected by MTT assay. Cell survival in control culture was set at 100%. Asterisks
denote p<0.05. Data are means from samples from 6 donors. (B) Chondrocyte apoptosis is verified by quantitation of subdiploid cells
analyzed with flow cytometry. Cells were fixed with 70% ethanol 24 hr after TNF- treatment and stained with propidium iodide before anal-
ysis with flow cytometry. Numbers denote percent subdiploid cells. Data are representative of samples from 4 donors. (C) Annexin V -
FITC/propidium iodide (PI) dual staining of chondrocytes analyzed by flow cytometry. Cells were stained 12 hr after TNF- treatment. Num-
bers in the right lower quadrant denotes percentages of early apoptotic chondrocytes (annexin V positive, PI negative). Data are repre-
sentative of 3 samples from different donors (Fig. 2 continued next).
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*The influence of phosphatase inhibitors on apoptosis-relat-
ed molecules
Lastly, we investigated the influence of Ro318220 and vana-
date on the level of apoptosis-related molecules. Cells were
incubated for 2, 4, 6, 8, 12, and 18 hr in TNF-alpha with or
without pretreatment and proteins were extracted. First, we
investigated the levels of Bcl-2 family proteins. The levels of
Mcl-1 and Bcl-2 began to decrease from 2 to 8 hr of culture
in Ro318220 and vanadate pretreated chondrocytes while
treatment with TNF-alpha alone did not exert any signifi-
cant effect on these proteins (Fig. 4). The expression patterns
of p53, MDM2, p21, FLICE inhibitory protein (FLIP), Bax,
Bcl-XL, and XIAP was not affected in any of the treatment
condition (data not shown). 
DISCUSSION
The objective of this study was to delineate the correlation
of JNK activation with TNF-alpha mediated chondrocyte
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Fig. 2. (Continued from the previous page) (D) Processing of caspase-3 revealed by Western blot. Cells were treated with TNF- for 6 hr and
lysates were assayed for caspase-3. T: TNF-alpha, VT: vanadate pretreatment followed by TNF-alpha, RT: Ro318220 pretreatment fol-
lowed by TNF- . Arrow denotes processed caspase-3 band. Data are representative of samples from 3 donors. (E) Chondrocyte death
induced by TNF-alpha and 500  M vanadate or 10  M Ro318220 is effectively inhibited by pan-caspase inhibitor, zVAD -FMK, implicat-
ing the involvement of caspase cascade. Cell death was measured by MTT assay, and the degree of cell death after 24 hr of incubation
without zVAD-FMK was set at 100%. Asterisks denote p<0.05. Data are means from samples from 5 donors.
Fig. 4. Patterns of Mcl-1 and Bcl-2 expression after TNF-alpha
treatment with or without vanadate, or Ro318220. Twenty micro-
gram of proteins were separated in SDS-PAGE gel and probed
with respective antibodies. T, TNF-alpha; VT, vanadate pretreat-
ment followed by TNF-alpha; RT, Ro318220 pretreatment followed
by TNF-alpha. Data are representative of samples from 3 donors.
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Fig. 3. (A) The influen-
ce of vanadate and
Ro318220 on NF- B
activation induced by
TNF-alpha in human
articular chondrocyte.
Nuclear extract was
prepared 15 min after
treatment with 10 ng/
mL of TNF-alpha, and
electrophoretic mobili-
ty shift assay was per-
formed. Data are rep-
resentative of samples from 3 donors. (B) Western blot for I B of
cytosolic extract of the same set of samples as in (A). (C) Western
blot for phosphorylated I B of cytosolic extract of the same set of
samples as in (A).
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Cdeath by using chemical inhibitors of JNK dephosphoryla-
tion. Our study shows that TNF-alpha signaling leads to
chondrocyte death in the presence of phosphatase inhibitors,
which induces prolonged JNK activation, and this pathway
is dependent on caspase cascade.
Activation of NF- B by TNF-alpha receptor associated
factor 2 (TRAF2) is postulated to serve as a primary mecha-
nism to protect cells against apoptosis (14). TNF-alpha also
plays a role of protection in apoptosis induced by other stim-
uli. A recent report (15), showed that TNF-alpha protects
chondrocytes from death induced by NO, and this protection
was conferred by 3 mediators, NF- B, phosphatydylinositol-3
kinase (PI-3K) which possibly could also stimulate NF- B
transcription activity, and cyclooxygenase-2. MAP kinases
lies in proximity to NF- B in TNF- signaling, and among
the 3 subtypes identified in mammalian cells, JNK and p38
kinases are strongly activated by extra- or intracellular stress
and inflammatory cytokines (16). It is thought that activation
of JNK and p38 kinases generally promotes an inhibition of
cell growth or promotion of cell death, while ERK is usually
strongly activated by growth factors and hormones that stim-
ulate cell growth and is involved in the regulation of cell pro-
liferation (17). Strong and prolonged activation of JNK has
been reported in response to a variety of stresses including
UV light, ionizing radiation and hydrogen peroxide, all of
which can induce apoptosis (18, 19). Because TNF-alpha
strongly activates JNK while it activates ERK only weakly
in many cells, it was postulated that JNK activation is involved
in TNF-alpha induced apoptosis (20). The role of JNK path-
way in TNF-alpha mediated signaling in chondrocytes has
not been elucidated, however. We have employed chemical
inhibitors of protein phosphatases, Ro318220 and vanadate
in order to inhibit dephosphorylation of activated JNK po-
tently, and our results show that inhibition of JNK dephos-
phorylation and resulting prolongation of JNK activation is
associated with chondrocyte death. In addition, actinomycin
D, another potentiator of TNF-mediated chondrocyte death
also led to significant prolongation of JNK activation. An
obligatory role of the JNK pathway has been documented
in various stress-induced apoptosis models. The duration of
JNK activation is thought to be a critical factor determining
cell survival or apoptosis, with transient activation leading
to cell proliferation and prolonged activation leading to apop-
tosis (18). The pattern of JNK activation induced by actino-
mycin D is reminiscent of JNK activation induced by Fas
in a neuroblastoma cell line, which was biphasic with first
peak at 15 min and second peak starting 2 hr after treatment
(21). From this result, it can be hypothesized that actinomycin
D also blocks the expression of a phosphatase that limits the
activation of JNK. The involvement of JNK in TNF-alpha
mediated apoptosis is not without debate (22, 23), however.
A recent study has shown that JNK is not required for TNF-
alpha mediated cell death and mouse embryonic fibroblast
deficient for JNK1 and JNK2 are somewhat more sensitive
to TNF-alpha, suggesting that JNK may play a role as sur-
vival factor (24). It is possible that low or basal levels of JNK
provide protection against cell death while sustained activa-
tion of JNK overrides the anti-apoptotic signals to promote
cell death. In addition, different means of JNK activation and/
or cell context may lead to different responses. Despite the
fact that sustained activation of JNK promotes cell death, the
molecular basis of how JNK contributes to TNF-alpha medi-
ated apoptosis remains to be elucidated.
In this study, the amount of cell death detected by MTT
assay tended to be higher than that by flow cytometry. The
extent of cell death can vary according to the method of anal-
ysis, and in our previous report, we found out that the propor-
tion of dead cell is higher by MTT assay compared to flow
cytometry (25). This discrepancy might stem from the loss
of dead cells in the process of cell collection inherent in flow
cytometry methodology. It is also possible that some of the
cell death detected by MTT assay represents non-apoptotic
cell death. 
Recently, we have observed that chondocytes transduced
with adenovirus encoding IkB-superreprresor, which exhibits
resistance to degradation resulting in selective inhibition of
NF- B activation, are induced to undergo apoptosis in res-
ponse to TNF-alpha. JNK activation is prolonged in this con-
dition of chondrocyte death (manuscript submitted). The
interrelationship between JNK and NF- B was suggested
by another report showing that the IKK/NF-kappaB path-
way negatively modulates TNF-alpha-mediated JNK acti-
vation, partly through NF-kappaB-induced XIAP, which is
specific to TNF-alpha signaling, and which contributes to
inhibition of apoptosis (26). In order to verify whether inhi-
bition of JNK inactivation might affect NF- B activation,
conversely, we looked at the pattern of NF- B activation and
I B degradation. Pretreatment with phosphatase inhibitors
did not have any discernible effects on NF- B activation.
Among the apoptosis related proteins, the expression of
Bcl-2 family proteins was most markedly changed. These
included the proteins related with protection of apoptosis,
such as Mcl-1 and Bcl-2. The involvement of the Bcl-2 family
proteins in protection from apoptosis induced by JNK acti-
vation was previously reported (27, 28).
We used chemical inhibitors of phosphatase and it could
be argued that the effect of JNK activation apart from the
primary stress induced damage or from other stress-induced
signaling pathway cannot be separated. In order to serve this
goal, a constitutively active JNK mutant which allows selec-
tive activation of the JNK cascade in the absence of any cel-
lular stress should be employed. In a recent report employing
such a mutant, deltaMEKK1:ER, it was revealed that addi-
tional inhibition of the PI3K cell survival pathway is neces-
sary to induce apoptosis in CC139 cells, even in conditions
of sustained activation of JNK (27).
In summary, we observed that sustained activation of JNK
induced by phosphatase inhibitors or actinomycin D after
572 H.S. Yoon, H.A. KimTNF- treatment is associated with chondrocyte death. This
effect may be due to blocking the expression of a TNF- in-
duced phosphatase that inactivates JNK. The expression of
protecting molecules of apoptosis, Mcl-1 and Bcl-2 was down-
regulated.
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